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Abstract 
Providers’ annotations are often used as classifiers for supervised machine learning. Occasionally, annotations of 
patient status are ‘naturally occurring’ in clinical documents, such as the morbidities assessment of patients starting 
dialysis. We aimed to examine the predictability of provider annotations for 8 clinical conditions. We retrieved the 
reported status (positive/negative) for these conditions from existing clinical documents for a cohort of dialysis 
patients at Indiana University. We used all available procedure, billing, laboratory, and prescription data to generate 
predictive models of physician annotations. The best performing algorithms yielded precision and recall metrics 
ranging from a low of 0.44 and 0.37 for heart failure and a high of 0.86 and 0.71 for cancer. We concluded that the 
relatively poor prediction of provider annotations points towards heterogeneous and inconsistent annotation 
behavior. A thorough assessment of provider accuracy should be done prior to using annotations generated during 
routine clinical care as gold-standard outcomes. 
Introduction 
A significant challenge in the domain of predictive modeling is obtaining annotated datasets. Such annotations are 
necessary to classify, and subsequently predict, outcomes of interest using supervised machine learning approaches. 
Commonly, annotations are generated by manual expert review when the outcome is not readily classifiable from 
available clinical documentation. Such expert review can be both time-consuming and resource-intensive, and often 
comprises the bulk of effort in a predictive modeling study. While automated algorithms can be used to perform 
classification tasks, review and interpretation by an expert is generally considered the gold standard. 
Such expert annotations are sometimes collected as part of routine clinical care. For example, sources for such 
annotations include disability forms, registration forms, and death certificates which contain physician 
documentation and interpretation of patient conditions and other outcomes.  The use of such ‘naturally occurring’ 
annotations in the clinical record is a convenient source of classifiers for predictive modeling.  However, the quality 
of these annotations may be influenced by numerous factors, including but are not limited to: 1) complexity of logic 
required for the annotation 2) cognitive and behavioral biases and heuristics 3) availability and access to necessary 
data 4) time constraints.  Thus, provider annotation performance is itself variable.  The objective of this study is to 
utilize machine learning techniques to assess the predictability of providers’ annotation performance for a set of 
common clinical conditions.  Specifically, we looked at nephrologists’ documentation of co-morbidities in patients 
with end-stage renal disease.  
Materials and Methods 
Patient Cohort 
Our cohort included all patients who started chronic dialysis therapy between 2005 through 2014 at Indiana 
University outpatient dialysis centers. This initial cohort consisted of 296 patients. Approvals were obtained from 
the Indiana University Institutional Review Board and the relevant institutions participating in the Indiana Network 
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for Patient Care (INPC) 
1
, a health information exchange that aggregates clinical data from all major health systems 
in Indianapolis, Indiana. 
Data extraction 
We extracted electronic medical record data (billing and procedure codes, medications, and laboratories) for all 
patients in the cohort for up to 10 years prior to the onset of End Stage Renal Disease (ESRD). We extracted these 
data using the INPC. 
For the provider annotations, we obtained the ESRD registration forms required by the Center for Medicare and 
Medicaid Services (CMS) for all new-onset dialysis patients (Figure 1).  The forms capture information on disease 
status (present/absent) for 23 conditions. Completion of these forms is part of the routine clinical care for all new 
ESRD patients 
2
. Each disease state has a corresponding checkbox to indicate the presence of disease, i.e. positive or 
negative outcome. 
Figure 1: The comorbid conditions section of the end stage renal disease patient registration form. 
Data preprocessing 
We integrated datasets extracted from multiple sources into a single master dataset for analysis. Data sets included 
each patient’s procedure and billing codes, medications, and laboratory data. To these data, we added as outcome 
measures 8 clinical conditions documented by the nephrologist on each patient’s registration form:  coronary artery 
disease, cancer, congestive heart failure, cerebrovascular accident, diabetes mellitus, peripheral vascular disease, 
chronic obstructive pulmonary disease, and retinopathy. All data analysis, pre-processing and decision model 
building were performed using version 3.7.12 of the Waikato Environment for Knowledge Analysis (Weka) 
software 
3
. 
A preliminary analysis of the dataset indicated that many of the outcomes were unbalanced, with the number of 
negative outcomes for each condition greatly outweighing the number of positive outcomes. We also noted that a 
number of patients in the dataset had no reported outcomes (not checked yes or no). To ensure better data quality, 
we excluded those patients from the dataset. This removed 20 patients from the initial cohort leaving 276 patients 
for our final analysis. We pre-processed the procedure and billing codes, prescription data into binary variables. 
Unlike the other datasets, the laboratory data were in numeric format. An initial data analysis indicated that these 
numeric values were highly distributed, and therefore, may reflect negatively on the decision model building. To 
address this challenge, the laboratory data was discretized into automatically-generated categorical ranges using 
Weka's built-in discretization support.  
To address the unbalanced nature of the master dataset, we decided to perform Synthetic Minority Oversampling 
Technique (SMOTE) to balance the dataset under evaluation. SMOTE boosted the negative outcomes in the dataset 
using synthetic data, further improving the quality of the decision model generation. 
 
Machine learning approach 
We sought to determine the ability to predict each outcome using the master dataset. We hypothesized that varying 
(a) feature subset sizes, (b) classification algorithms and (c) boosting percentages would yield varying performance 
metrics. To test our hypothesis, we built multiple decision models using varying combinations of the 
abovementioned criteria. The classification algorithms selected for our study were simple logistic regression (SLR), 
naïve Bayes (NB), random forest (RF), and J48 decision tree (J48). These algorithms were selected based on their 
widespread use in various matching learning studies, and track record of yielding optimal results 
4, 5
. 
The master dataset had a total of 7655 features. Existing literature indicates that using irrelevant features for 
decision model building may lead to over-fitting 
6
. To prevent this, we limited our feature space by ranking each 
feature in order of significance using Weka's information gain approach, based on the Kullback-Leibler divergence 
7
, a widely used method for selecting optimal features for machine learning. From the ranked feature set, we selected 
feature subsets of 50, 75, 100 and 125 for study. These feature subset sizes were selected based on preliminary 
analysis of what subset sizes provided the best results for the dataset, coupled with previous literature that 
recommended smaller feature subset sizes for use 
8-10
. Due to the limited dataset, we adopted ten-fold cross 
validation, aka rotation estimation, a widely used train/test method prescribed for use with relatively small datasets 
11
. 
We built and tested decision models using combinations of the aforementioned feature subset sizes, classification 
algorithms and boosting percentages (Figure 2). Given 4 feature subset sizes, 4 algorithms, and 3 boosting 
percentages, this resulted in a total of 48 (4 x 4 x 3) decision models for each outcome being tested. 
 
Figure 2. The study approach from the selection of alternative feature subsets to decision model building and the 
evaluation of results. Synthetic Minority Oversampling Technique (SMOTE), simple logistic regression (SLR), 
naïve Bayes (NB), random forest (RF), and J48 decision tree (J48), receiver operating characteristic curve (ROC). 
 
Results 
The overall predictive accuracy of providers’ positive annotations was poor to fair, with an average recall of 0.6 and 
no F-measure exceeding 0.8. Results of our supervised machine learning are summarized in Table 1, which shows 
the best performing learning algorithm for each condition’s annotations, along with the corresponding accuracy 
metrics of precision, recall, F –measure, and area under the receiver operating characteristic curve (ROC). 
Outcome Algorithm Class Precision Recall F-measure ROC 
CAD NB 
Positive 0.731 0.679 0.704 
0.923 
Negative 0.964 0.972 0.968 
Cancer NB 
Positive 0.857 0.706 0.774 
0.93 
Negative 0.981 0.992 0.987 
CHF SL 
Positive 0.436 0.37 0.4 
0.755 
Negative 0.878 0.904 0.891 
CVA NB 
Positive 0.619 0.722 0.667 
0.952 
Negative 0.98 0.969 0.975 
DM NB 
Positive 0.875 0.368 0.519 
0.927 
Negative 0.955 0.996 0.975 
PVD NB 
Positive 0.769 0.526 0.625 
0.945 
Negative 0.966 0.988 0.977 
COPD NB 
Positive 0.667 0.667 0.667 
0.928 
Negative 0.981 0.981 0.981 
Retinopathy NB 
Positive 0.354 0.81 0.493 
0.907 
Negative 0.982 0.878 0.928 
Coronary artery disease (CAD), congestive heart failure (CHF), cerebrovascular accident (CVA), diabetes mellitus 
(DM), hypertension (HTN), peripheral vascular disease (PVD), chronic obstructive pulmonary disease (COPD), 
simple logistic regression (SL), naïve Bayes (NB), receiver operating characteristic curve (ROC).  
Table 1: Performance metrics of the best performing algorithm for providers’ annotations of medical conditions. 
 
An exceedingly high overall predictive accuracy (above 0.9) was achieved for the negative annotations and 
subsequently the ROC, which can be explained by the high prevalence of negative annotations in the data. In Figure 
3, we show the estimated precision for each positively annotated outcome using different decision models and 
different numbers of selected features. Similarly, the estimated recall for each positively annotated outcome using 
different numbers of selected features is shown in Figure 4. In some cases, the predictive accuracy was variable 
when comparing between different decision models. 
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Coronary artery disease (CAD), congestive heart failure (CHF), cerebrovascular accident (CVA), diabetes mellitus 
(DM), hypertension (HTN), peripheral vascular disease (PVD), chronic obstructive pulmonary disease (COPD), 
simple logistic regression (SL), naïve Bayes (NB), random forest (RF), J48 trees (J48). 
Figure 3: Estimated precision across each positively annotated outcome graphed by varying feature subset size for 
each decision model. 
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Coronary artery disease (CAD), congestive heart failure (CHF), cerebrovascular accident (CVA), diabetes mellitus 
(DM), hypertension (HTN), peripheral vascular disease (PVD), chronic obstructive pulmonary disease (COPD), 
simple logistic regression (SL), naïve Bayes (NB), random forest (RF), J48 trees (J48). 
 
Figure 4: Estimated recall across each positively annotated outcome graphed by varying feature subset size for each 
decision model. 
 
Discussion 
Extensive literature exists on the utility of machine learning in predicting clinically relevant outcomes. Literature 
supports that many conditions such as heart failure 
12, 13
, diabetes 
14
, and cancer 
8
 can be predicted with high 
accuracy. However, in our study results show fair ability, at best, to predict these provider-reported clinical 
conditions in our cohort. This indicates wide heterogeneity in how providers annotate these clinical outcomes which 
is suggestive of a mismatch between annotations and the true state of these clinical conditions. This is further 
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supported by our previous findings where expert-designed phenotypes outperformed providers’ annotations to 
determine the true state of clinical conditions for this cohort 
15
. 
The precision and recall measures for the best performing positive annotation prediction model were as low as 0.44 
and 0.37 respectively for heart failure and as high as 0.86 and 0.71 for cancer. This indicates an overall fair 
prediction for positive annotations. The notable performance differences across the different decision models in 
many instances such as the precision for cancer and the recall for retinopathy, makes even this fair prediction likely 
to be an overestimate. 
The main strength of our study is the presence of pre-existing annotations that allowed us to approach the behavioral 
aspect of providers’ annotation as the main target. This is in contrast to the usual prediction of the true states of 
diseases that are more common in the literature and where annotations are created by the research team. We believe 
that the degree of prediction for un-intervened annotations such as those extracted from routine clinical care have 
important value for studying the behavioral aspects of providers’ decision making process. For example, highly 
predictable annotations suggest a systematic annotation behavior by providers, regardless whether correct or not for 
the true disease state, whereas low predictability indicates a more heterogeneous behavior. Such information can be 
used for further research and in the development of Clinical Decision Support (CDS) systems that target providers’ 
decision making process. The use of machine learning to understand physician annotation behavior has not been 
previously studied, and, in our opinion, deserves further exploration by the informatics research community as it 
impacts the rigor of data used for other purposes. For the meantime, providers’ annotations as a proxy for the true 
state of clinical conditions should be utilized with caution. 
There are several limitations to this study. First, this is a defined cohort with a sample of only 276 patients. Although 
this represents a 10 year longitudinal cohort, the size of the cohort is a limiting factor and therefore our findings may 
not be generalizable. Second, data mining is subject to the known nuances of missing, corrupted, inconsistent, or 
non-standardized data 
16
. However, this was reduced with the use of broad access and standardized retrieval via the 
Indiana Network for Patient Care network. Further, we adopted a series of best practices advocated in machine 
learning literature as solutions to pitfalls caused by missing, corrupted, inconsistent, unbalanced or non-standardized 
data. This means that despite of these limitations, we are following the best possible solutions to build decision 
models using the data at hand. 
 
Conclusions 
We cautiously conclude that providers’ annotations of key clinical outcomes are limited based on the lack of their 
predictability. We suspect that this limitation is likely present in other clinical settings, though this needs further 
exploration. We suggest that the use of providers’ annotations extracted from clinical documents be carefully 
examined and appropriately challenged for clinical data analytics research. Finally, the use of machine learning 
techniques can be a valuable tool in understanding annotations patterns in order to guide development of decision 
support systems. 
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